Dr Colin Biggin Moves to Managing Director and CEO, Dr Matthew Harris Resigns from the Board
Sydney, Australia 30 October 2019 – Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, is pleased to announce that interim-CEO, Dr Colin Biggin, has moved to Managing Director and CEO of the Company, to lead Clarity through the next stages of clinical development and commercialisation. Dr Biggin’s background in radiopharmaceutical development…